Cameron is a Partner on the Biotherapeutics group at Deerfield and joined the Firm in 2014. Prior to Deerfield, he worked for and on behalf of Eleven Biotherapeutics, Inc. as a director since 2009. Previous to that, he was Manager of the Business Development and Operations team at Constellation Pharmaceuticals, Inc. and a Senior Associate at Third Rock Ventures, LLC. Cameron holds a PhD and SM in Biological Engineering and an SB in Mechanical Engineering from the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.